ALBO
Albireo Pharma, Inc. Common Stock
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
43 hedge funds and large institutions have $17.8M invested in Albireo Pharma, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 5 closing their positions.
Holders
43
Holders Change
+1
Holders Change %
+2.38%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
17
Reduced
9
Closed
5
Calls
$60K
Puts
$394K
Net Calls
-$334K
Net Calls Change
-$946K
Top Buyers
Top Sellers
1 |
VM
1
VHCP Management
New York
|
$0 |
2 |
2
Millennium Management
New York
|
$46K |
3 |
FNYS
3
First New York Securities
New York
|
$666K |
4 |
VAM
4
Visium Asset Management
New York
|
$0 |
5 |
O
5
OrbiMed
New York
|
$1.09M |